Anti-Human CMV Therapeutic Antibody (TCN-202)
Recombinant Human monoclonal antibody expressed in CHO binding to Human CMV. TCN-202, a broadly protective, fully human monoclonal antibody in development for the treatment of human cytomegalovirus (CMV) infection. TCN-202 is directed against a universal target within CMV variations, and this Phase 1 study is a significant step in bringing an important new treatment to patients with CMV infection.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-179CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CMV |
| Species Reactivity | Human |
| Type | Antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |